These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

384 related articles for article (PubMed ID: 26385352)

  • 1. Antileukotrienes in upper airway inflammatory diseases.
    Cingi C; Muluk NB; Ipci K; Şahin E
    Curr Allergy Asthma Rep; 2015 Nov; 15(11):64. PubMed ID: 26385352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antileukotrienes in adenotonsillar hypertrophy: a review of the literature.
    Kar M; Altıntoprak N; Muluk NB; Ulusoy S; Bafaqeeh SA; Cingi C
    Eur Arch Otorhinolaryngol; 2016 Dec; 273(12):4111-4117. PubMed ID: 26980339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Leukotrien antagonists in the treatment of allergic rhinitis and comorbidities].
    Sacre Hazouri JA
    Rev Alerg Mex; 2008; 55(4):164-75. PubMed ID: 19058495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antileukotriene drugs: clinical application, effectiveness and safety.
    Riccioni G; Bucciarelli T; Mancini B; Di Ilio C; D'Orazio N
    Curr Med Chem; 2007; 14(18):1966-77. PubMed ID: 17691939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antileukotrienes in asthma: present situation.
    García-Marcos L; Schuster A
    Expert Opin Pharmacother; 2001 Mar; 2(3):441-66. PubMed ID: 11336598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting cysteinyl leukotrienes in patients with rhinitis, sinusitis and paranasal polyps.
    Parnes SM
    Am J Respir Med; 2002; 1(6):403-8. PubMed ID: 14720027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A review on leukotrienes and their receptors with reference to asthma.
    Singh RK; Tandon R; Dastidar SG; Ray A
    J Asthma; 2013 Nov; 50(9):922-31. PubMed ID: 23859232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Effect of Antileukotrienes on the Results of Postoperative Treatment of Paranasal Sinuses in Patients with Non-Steroidal Anti-Inflammatory Drug-Exacerbated Respiratory Disease.
    Stryjewska-Makuch G; Humeniuk-Arasiewicz M; Jura-Szołtys E; Glück J
    Int Arch Allergy Immunol; 2019; 179(4):281-289. PubMed ID: 31091524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Zafirlukast in treatment of nasal polyps in patients with aspirin intolerant bronchial asthma--preliminary report].
    Modrzyński M; Zawisza E; Rapiejko P
    Pol Merkur Lekarski; 2002 Mar; 12(69):224-7. PubMed ID: 12053594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute effects of antileukotrienes on sinonasal polyposis and sinusitis.
    Parnes SM; Chuma AV
    Ear Nose Throat J; 2000 Jan; 79(1):18-20, 24-5. PubMed ID: 10665187
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of leukotrienes in the management of asthma: biology and clinical therapy.
    Leff AR
    Annu Rev Med; 2001; 52():1-14. PubMed ID: 11160764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Benefit-risk assessment of antileukotrienes in the management of asthma.
    García-Marcos L; Schuster A; Pérez-Yarza EG
    Drug Saf; 2003; 26(7):483-518. PubMed ID: 12735786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New perspectives for asthma treatment: anti-leukotriene drugs.
    García-Marcos L; Schuster A
    Pediatr Allergy Immunol; 1999 May; 10(2):77-88. PubMed ID: 10478608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Status of leukotrienes in the pathophysiology of asthma. Necessity for antileukotrienes treatment].
    Fal AM; Kopeć A
    Pneumonol Alergol Pol; 2010; 78(1):68-73. PubMed ID: 20162521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of antileukotrienes in asthma management.
    Tan RA
    Curr Opin Pulm Med; 1998 Jan; 4(1):25-30. PubMed ID: 9526901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Asthma treatment: antileukotriene drugs.
    O'Byrne PM
    Can Respir J; 1998; 5 Suppl A():64A-70A. PubMed ID: 9753521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Montelukast: new therapeutic option in patients with nasal polyps associated to respiratory allergic disease].
    Almeida Arvizu V; Guidos Fogelbach G; Sánchez Sánchez B; Vásquez Nava F; Matta Campos J; López Medina L; Rivera Pérez J; Mejía Covarrubias F; Montero Mora P
    Rev Alerg Mex; 2005; 52(4):151-8. PubMed ID: 16268183
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of cysteinyl leukotrienes and their receptors in refractory nasal polyps.
    Du J; Ba L; Zhou J; Yu L; Liu R; Zhang J; Liu F; Xian J; Liu S; Liu Y
    Prostaglandins Leukot Essent Fatty Acids; 2017 Nov; 126():39-48. PubMed ID: 29031394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of leukotriene antagonists in childhood asthma.
    Krawiec ME; Wenzel SE
    Curr Opin Pediatr; 1999 Dec; 11(6):540-7. PubMed ID: 10590913
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 20.